On the role of seizure activity and endogenous excitatory amino acids in mediating seizure-associated hippocampal damage.
D000109:Acetylcholine / Q000633:toxicity; D000200:Action Potentials; D000596:Amino Acids / Q000502:physiology* / Q000633:toxicity; D000818:Animals; D001224:Aspartic Acid / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects; D003712:Dendrites / Q000473:pathology; D004827:Epilepsy / Q000473:pathology*; D005971:Glutamates / Q000633:toxicity; D006624:Hippocampus / Q000473:pathology* / Q000503:physiopathology; D007608:Kainic Acid / Q000633:toxicity*; D018377:Neurotransmitter Agents / Q000633:toxicity; D012640:Seizures / Q000473:pathology / Q000503:physiopathology*; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000633:toxicity
D000596:Amino Acids; D005971:Glutamates; D018377:Neurotransmitter Agents; D001224:Aspartic Acid; D005680:gamma-Aminobutyric Acid; D000109:Acetylcholine; D007608:Kainic Acid